Trial Protocol ID USOR 22244_IM048022

Trial Description

A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT) in Participants with Newly Diagnosed Multiple Myeloma (NDMM)

Contact us regarding Clinical Trials at or call us at 877-664-7724


  • Jose Méndoza, M.D.

Disease Types


  • Bristol-Myers Squibb NCT ID

  • NCT05827016